Massachusetts Institute of Technology researchers developed antibodies that are able to bind better to all four serotypes of the dengue virus, a possible step toward effective vaccines, according to a study in the Proceedings of the National Academy of Sciences. The researchers used an antibody called 4E11, and a mutated antibody allowed significantly improved binding to two serotypes and lesser improvements for the other two.
Researchers create mutated antibodies to fight dengue
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan